Tom DiLenge
Private Equity Investor bei Flagship Pioneering
Ursprung des Netzwerks ersten Grades von Tom DiLenge
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
University of Virginia
391
| College/University | Other Consumer Services | 391 |
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts.
174
| Private Company | Investment Managers | 174 |
Fordham University
 Fordham University Other Consumer ServicesConsumer Services Fordham University provides college and university. It offers undergraduate colleges and graduate & professional schools. The company was founded in 1841 and is headquartered in Bronx, NY.
139
| College/University | Other Consumer Services | 139 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Tom DiLenge
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| Massachusetts Institute of Technology | College/University | Director/Board Member Doctorate Degree Doctorate Degree Doctorate Degree Graduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree Graduate Degree | |
| AXCA HEALPAR | Biotechnology | Director/Board Member Founder Director/Board Member Director of Finance/CFO Founder Founder Chairman Corporate Officer/Principal | |
| EVELO BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member Founder Director/Board Member Founder Chairman Director/Board Member | |
| SERES THERAPEUTICS, INC. | Biotechnology | Founder Founder Founder Chairman Director of Finance/CFO | |
Cellarity Inc.
 Cellarity Inc. BiotechnologyHealth Technology Cellarity Inc. engages in the operation of platform to design medicines targeting the full cellular and molecular complexity of disease. The company was founded by Avak Kahvejian, James J. Collins, Noubar Afeyan, and Nicholas Plugis in 2017 and is headquartered in Cambridge, MA. | Biotechnology | Founder Chief Executive Officer Founder Chairman President | |
Generate Biomedicines, Inc.
 Generate Biomedicines, Inc. BiotechnologyHealth Technology Generate Biomedicines, Inc. is a drug generation company that has developed a machine learning-powered multimodality generative biology platform capable of generating new drugs on demand across a wide range of biologic modalities. Generate Biomedicines is based in Somerville, MA. The platform seamlessly integrates computational and wet lab capabilities, improving the speed at which targets and therapeutics are identified and validated, the specificity of target engagement by generated proteins, and the cost of identifying and developing clinical candidates. The company's platform represents a potentially fundamental shift in what's possible in the field of therapeutic development, addressing key challenges of drug discovery and drastically expanding the available search space for novel biomedicines. The company was founded in 2018 by Poorya Hosseini, Molly Gibson, Geoffrey von Maltzahn, Avak Kahvejian, Gevorg Grigoryan. Michael T. Nally has been the CEO of the company since 2018. | Biotechnology | Founder Founder Founder Chief Executive Officer President | |
Ohana Biosciences, Inc.
 Ohana Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Ohana Biosciences, Inc. operates early stage biotechnology firm. The company is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Tessera Therapeutics, Inc.
 Tessera Therapeutics, Inc. BiotechnologyHealth Technology Tessera Therapeutics, Inc. engages in science company. It offers scientists and doctors the ability to write and rewrite small and large therapeutic messages into the genome, thereby curing diseases at their source. The company is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Founder Director/Board Member Founder | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| KALEIDO BIOSCIENCES, INC. | Pharmaceuticals: Major | Chairman Founder Chief Administrative Officer Founder | |
Inari Agriculture, Inc.
 Inari Agriculture, Inc. BiotechnologyHealth Technology Inari Agriculture, Inc. engages biotechnology research and development. It specializes in plant breeding technology. The company was founded by David Berry, Ignacio Martinez, George Church, and Steve Jacobsen in 2016 and is headquartered in Cambridge, MA. | Biotechnology | Founder Founder Founder Director/Board Member | |
Montai Health, Inc.
 Montai Health, Inc. Packaged SoftwareTechnology Services Montai Health, Inc. is a company that is using its pioneering AI-powered Conecta™ platform to develop Anthromolecule™ medicines that will treat and preempt chronic diseases to improve health outcomes for the 2 billion people worldwide living with these diseases. The company is based in Cambridge, MA. Montai Health is unlocking the potential of Anthromolecule™ chemistry with its pioneering AI-powered Conecta™ platform to develop breakthrough small-molecule medicines that will treat and preempt chronic diseases to improve health outcomes for the two billion people worldwide living with these diseases. The company was founded by Hok Hei Tam, Michael Wong, David Kolesky, Mary Margaret Hastings Georgiadis. Mary Margaret Hastings Georgiadis has been the CEO since incorporation. | Packaged Software | Director/Board Member Director/Board Member Founder Chief Operating Officer | |
Indigo Ag, Inc.
 Indigo Ag, Inc. BiotechnologyHealth Technology Indigo Ag, Inc. provides microbial solutions. The company was founded by Noubar Afeyan, David A. Berry, and Geoffrey von Maltzahn in 2013 and is headquartered in Charlestown, MA. | Biotechnology | Founder Founder Founder Director/Board Member | |
| Harvard Medical School | College/University | Doctorate Degree Graduate Degree Corporate Officer/Principal Doctorate Degree | |
| MODERNA, INC. | Biotechnology | Director/Board Member Director/Board Member Founder Director/Board Member | |
| University of California San Diego | College/University | Doctorate Degree Graduate Degree Corporate Officer/Principal Graduate Degree | |
Invaio Sciences, Inc.
 Invaio Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Invaio Sciences, Inc. operates as multi-platform technology company. The firm develops multi-platform technology company that unlocks the potential of planet's interdependent natural systems to solve pressing agriculture, nutrition and environmental challenges. The company was founded in 2018 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Chief Executive Officer Founder Founder | |
Cobalt Biomedicine, Inc.
 Cobalt Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Cobalt Biomedicine, Inc. engages in the development of therapeutic based drugs. The company was founded in 2017 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer | |
| New York University | College/University | Masters Business Admin Graduate Degree Undergraduate Degree | |
American Bar Association
 American Bar Association Miscellaneous Commercial ServicesCommercial Services American Bar Association provides legal services. It provides law school accreditation, continuing legal education, legal information and other services to assist legal professionals. The firm has members which include judges, court administrators, law professors, and non-practicing attorneys. The company was founded on August 21, 1878 and is headquartered in Chicago, IL. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| University of Oxford | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree | |
Ampersand Biomedicines
 Ampersand Biomedicines BiotechnologyHealth Technology Ampersand Biomedicines is an American company that designs programmable medicines that work precisely where needed in the body and nowhere else. The company's computationally powered platform identifies ideal addresses for drug localization and informs the design of and-body™ therapeutics that have the optimal therapeutic effect. The result is smarter biologic medicines that target the site of disease without affecting healthy tissue or cells. Ampersand is enabling potent mechanisms to treat disease by creating and programming therapeutics that are more efficacious, without compromising on safety or tolerability. The company was founded in 2020 at Flagship Labs, a unit of Flagship Pioneering. Jason Gardner has been the CEO of the company since 2023. | Biotechnology | Founder Chief Executive Officer Founder | |
Inzen Therapeutics, Inc.
 Inzen Therapeutics, Inc. BiotechnologyHealth Technology Part of Sonata Therapeutics, Inc., Inzen Therapeutics, Inc. is discovering and developing a novel class of medicines based on thanokine biology. The company is based in Cambridge, MA. Thanokine biology offers the potential for unprecedented approaches to prevent and treat cancer, fibrotic disorders, immune-inflammatory disorders, metabolic disorders, and degenerative diseases. Inzen's thanokine product platform applies advances in mass spectrometry and machine learning, novel probes, unique assays, genetic and chemical biological technologies to characterize thanokine biology at scale and create drug candidates. Inzen Therapeutics harnesses signals of the cellular microenvironment to treat serious diseases. The company was founded by Flagship Pioneering, a life sciences innovation enterprise that conceives, resources, and develops first-in-category companies to transform human health and sustainability. | Biotechnology | Director/Board Member Director/Board Member President | |
Cygnal Therapeutics, Inc.
 Cygnal Therapeutics, Inc. BiotechnologyHealth Technology Cygnal Therapeutics, Inc. develops drugs for cancer, immunological diseases and regenerative processes. The company was founded by Noubar Afeyan, Avak Kahvejian and Jordi Mata-Fink in 2017 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Founder Director/Board Member | |
Profound Therapeutics
 Profound Therapeutics Pharmaceuticals: OtherHealth Technology Profound Therapeutics is a company that is focused on discovering new medicines by expanding the human proteome. The company is based in Cambridge, MA. The company uses their platform, Profoundry, to identify and validate proteins and understand their therapeutic potential. This results in a growing database of novel proteins and their roles in health and disease. The company was founded in 2020 by Avak Kahvejian, who has been the CEO since then. | Pharmaceuticals: Other | Chairman President Founder | |
| EXACT SCIENCES CORPORATION | Medical Specialties | Director of Finance/CFO Director/Board Member Founder | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree | |
| RUBIUS THERAPEUTICS | Biotechnology | Founder Director/Board Member Director of Finance/CFO | |
Midori USA, Inc.
 Midori USA, Inc. Miscellaneous Commercial ServicesCommercial Services Midori USA, Inc. develops cellulosic technology for conversion of biomass to fuels. It offers biomass barrier technology that melts and digests biomass into sugars with a solid, recyclable catalyst. The company was founded by J. M. Geremia and Brian Baynes in 2008 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Chairman Director/Board Member Director/Board Member | |
LS Dissolution, Inc.
 LS Dissolution, Inc. Chemicals: Major DiversifiedProcess Industries LS Dissolution, Inc. engages in the production of petroleum replacement products and industrial chemicals. It offers chemical and fuel products. The company was founded by George M. Church, Christopher Somerville, Noubar B. Afeyan and Jay D. Keasling in 2005 and is headquartered in South San Francisco, CA. | Chemicals: Major Diversified | Founder Founder Founder | |
Repertoire Immune Medicines, Inc.
 Repertoire Immune Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services Repertoire Immune Medicines, Inc. operates as a clinical-stage biotechnology company. It focuses on the immune system to prevent, treat, and cure cancer, autoimmune disorders, and infectious diseases. The company was founded by Noubar Afeyan and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member Founder Director/Board Member | |
| OMEGA THERAPEUTICS, INC. | Biotechnology | Director/Board Member Founder Founder | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| BG MEDICINE, INC. | Medical Specialties | Chairman Founder Director of Finance/CFO | |
| T2 BIOSYSTEMS, INC. | Medical Specialties | Director/Board Member Director/Board Member Founder | |
CiBO Technologies, Inc.
 CiBO Technologies, Inc. Packaged SoftwareTechnology Services CiBO Technologies, Inc. is a science-driven software company which engage sin the modelling and simulation of agricultural ecosystems. The firm offers CIBO and CIBO Plus software products. The company was founded by Ignacio Bemposta Martinez and Bruno Basso in 2015 and is headquartered in Cambridge, MA. | Packaged Software | Director/Board Member Founder Director/Board Member | |
| Washington University in St. Louis | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Cambridge | College/University | Undergraduate Degree Undergraduate Degree | |
| Middlebury College | College/University | Undergraduate Degree Undergraduate Degree | |
| EDITAS MEDICINE, INC. | Biotechnology | Director/Board Member Founder | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 48 |
| Vereinigtes Königreich | 3 |
Sektoral
| Health Technology | 27 |
| Consumer Services | 11 |
| Commercial Services | 9 |
| Technology Services | 3 |
| Process Industries | 3 |
Operativ
| Director/Board Member | 300 |
| Corporate Officer/Principal | 130 |
| Founder | 122 |
| Undergraduate Degree | 78 |
| Private Equity Investor | 68 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Noubar Afeyan | 76 |
| John Casteen | 45 |
| George Church | 45 |
| Paul Conley | 39 |
| Harry Wilcox | 33 |
| Michael Rosenblatt | 31 |
| Ed Kania | 31 |
| David Berry | 31 |
| John Mendlein | 27 |
| Theo Melas-Kyriazi | 26 |
| Ignacio Martinez | 21 |
| Geoffrey von Maltzahn | 15 |
| Diego Miralles | 14 |
| Joseph William Little | 14 |
| Jonathan Ian Schwartz | 13 |
- Börse
- Insiders
- Tom DiLenge
- Unternehmensverbindungen
